Company
PT Merck Tbk
Headquarters: Jakarta Timur, Indonesia
Employees: 407
Market Cap
Rp1.783 Trillion
IDR as of July 1, 2024
US$108.9 Million
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. The company operates in the healthcare, life science, and performance materials sectors. It offers health care products in the areas of allergies, endocrinology, fertility, general medicine, neuro degenerative diseases, and oncology. The company also engages in discovery, development, manufacturing, and diagnostics of drugs. In addition, it offers liquid crystals and OLED materials for displays, materials for integrated circuits, pigments for coatings or colour cosmetics, and functional materials for energy solutions. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
PT Merck Tbk has the following listings and related stock indices.
Stock: IDX: MERK wb_incandescent